Invus Global Management, LLC 13D/13G Filings for enGene Holdings Inc. (ENGN)

Invus Global Management, LLC 13D and 13G filings for enGene Holdings Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-05-05
10:59 am
Purchase
2026-03-3113GENGENE THERAPEUTICS INC
ENGN
Invus Global Management, LLC5,253,159
7.800%
1,008,600increase
(+23.76%)
Filing